Nachrichten zur Rocket Pharmaceuticals Corp. Aktie

NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of …

Rocket Pharmaceuticals plunges after a patient death in its Danon disease study, prompting a voluntary dosing pause. The FDA puts…

Shares of Rocket Pharmaceuticals (NASDAQ:RCKT) sank nearly 60% on Tuesday morning after the company disclosed that the US Food and…

RCKT incurs a narrower-than-expected fourth-quarter 2024 loss. The company provides updates on its pipeline candidates.…

…

RCKT incurs narrower-than-expected third-quarter 2024 loss. The company provides updates on its pipeline candidates.…

…

The Global Regenerative Medicine Market Size was Valued at USD 31.90 Billion in 2023 and the Worldwide Regenerative Medicine Market…

…

Rocket Pharmaceuticals (RCKT) first-quarter earnings beat estimates. Devoid of marketed drugs, the company did not report any revenues during the…

…

…

…

Rocket Pharmaceuticals director sells over $7.79 million in company stock…

Rocket Pharmaceuticals executive sells over $69k in company stock…

…

Rocket Pharmaceuticals (RCKT) fourth-quarter earnings beat estimates. Devoid of marketed drugs, the company did not report any revenues during the…